In a study completed by the Alzheimer’s Association, it was calculated that ten percent of Americans age 65 and older suffer from Alzheimer’s disease. Over five million Americans have been diagnosed, and the at-risk population is growing steadily. People are living longer, which creates a larger population of seniors. Currently, there is no available cure for Alzheimer’s disease. Medical treatments center around the management of symptoms. Unfortunately, the primary medications often result in harmful side effects. Nausea, vomiting, indigestion, decreased appetite chest pain and cramps are common issues for Alzheimer’s patients. Long-term problems include stroke, heart and liver problems, and kidney problems. Exploratory studies are continuing to prove that specific elements found in the Cannabis sativa plant are helpful in treating Alzheimer’s disease. Cannabinoids have the capability to remove the buildup of senile plaques and also inhibit the inflammatory process that hastens the progression of Alzheimer’s disease. A four-week trial of ten patients with Alzheimer’s disease showed a substantial decrease in delusions, agitations, irritability, apathy, sleep and distress for those who were given medical cannabis oil. Another study of mice with advanced Alzheimer’s disease showed that a combination of THC and CBD decreased memory impairment. Ongoing research and studies continue to demonstrate the benefits of cannabinoids as a preventative medication and as part of a regular program of treatment for Alzheimer’s disease. While more research is needed, people are finding relief, success and hope through cannabis. Hopefully, these studies will focus more attention on both the disease and the potential for natural treatment. There’s no harmful side effects associated with cannabis treatment.